Status: Recruiting
A Study to Evaluate the Performance and Safety of Artelac® Complete MDO® Versus VISMED® MULTI Eye Drops in the Management of Moderate to Severe Dry Eye Disease
A Double-Masked, Randomized, Parallel Group, Non-Inferiority Study to Evaluate the Performance and Safety of Artelac® Complete MDO® Versus VISMED® MULTI Eye Drops in the Management of Moderate to Severe Dry Eye Disease
Participants needed: 160
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Dr. Gerhard Mann chem.-pharm. Fabrik GmbHUpdated: May 18, 2026Locations: 5
Eligibility criteria
Subject must be of legal age (at least 18) on the date the Informed Consent Form... [+6]
Subject who has received ocular surgery, including laser surgery, intraocular in... [+10]